These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1559 related articles for article (PubMed ID: 14684627)

  • 1. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
    Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
    Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
    J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.
    Wang X; Weng LP; Yu Q
    Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.
    Brown KJ; Hendry IA; Parish CR
    J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling.
    Forsten-Williams K; Chua CC; Nugent MA
    J Theor Biol; 2005 Apr; 233(4):483-99. PubMed ID: 15748910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate.
    Ashikari-Hada S; Habuchi H; Sugaya N; Kobayashi T; Kimata K
    Glycobiology; 2009 Jun; 19(6):644-54. PubMed ID: 19254961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
    Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J
    Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear localization of basic fibroblast growth factor is mediated by heparan sulfate proteoglycans through protein kinase C signaling.
    Hsia E; Richardson TP; Nugent MA
    J Cell Biochem; 2003 Apr; 88(6):1214-25. PubMed ID: 12647303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex.
    Wang F; Lu W; McKeehan K; Mohamedali K; Gabriel JL; Kan M; McKeehan WL
    Biochemistry; 1999 Jan; 38(1):160-71. PubMed ID: 9890894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
    Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM
    Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
    McKeehan WL; Kan M
    Mol Reprod Dev; 1994 Sep; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells.
    Delehedde M; Deudon E; Boilly B; Hondermarck H
    Exp Cell Res; 1996 Dec; 229(2):398-406. PubMed ID: 8986623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2.
    Wu Y; Chen Z; Ullrich A
    Biol Chem; 2003 Aug; 384(8):1215-26. PubMed ID: 12974390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both FGF1 and bcl-x synthesis are necessary for the reduction of apoptosis in retinal pigmented epithelial cells by FGF2: role of the extracellular signal-regulated kinase 2.
    Bryckaert M; Guillonneau X; Hecquet C; Courtois Y; Mascarelli F
    Oncogene; 1999 Dec; 18(52):7584-93. PubMed ID: 10602518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor (FGF)-2 mediates cell attachment through interactions with two FGF receptor-1 isoforms and extracellular matrix or cell-associated heparan sulfate proteoglycans.
    Richard C; Roghani M; Moscatelli D
    Biochem Biophys Res Commun; 2000 Sep; 276(2):399-405. PubMed ID: 11027487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin AT1 receptor upregulates expression of basic fibroblast growth factor, basic fibroblast growth factor receptor and coreceptor in human coronary smooth muscle cells.
    Skaletz-Rorowski A; Pinkernell K; Sindermann JR; Schriever C; Müller JG; Eschert H; Breithardt G
    Basic Res Cardiol; 2004 Jul; 99(4):272-8. PubMed ID: 15221345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific binding by FGF and FGF receptors to endogenous heparan sulfates.
    Friedl A; Filla M; Rapraeger AC
    Methods Mol Biol; 2001; 171():535-46. PubMed ID: 11450267
    [No Abstract]   [Full Text] [Related]  

  • 18. Is the sensitivity of cells for FGF-1 and FGF-2 regulated by cell surface heparan sulfate proteoglycans?
    Zhou FY; Owens RT; Hermonen J; Jalkanen M; Höök M
    Eur J Cell Biol; 1997 Jun; 73(2):166-74. PubMed ID: 9208230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells.
    Kim MS; Kim CJ; Jung HS; Seo MR; Juhnn YS; Shin HY; Ahn HS; Thiele CJ; Chi JG
    J Pathol; 2004 Jan; 202(1):103-12. PubMed ID: 14694527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.
    Presta M; Oreste P; Zoppetti G; Belleri M; Tanghetti E; Leali D; Urbinati C; Bugatti A; Ronca R; Nicoli S; Moroni E; Stabile H; Camozzi M; Hernandez GA; Mitola S; Dell'Era P; Rusnati M; Ribatti D
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):71-6. PubMed ID: 15514208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 78.